Press Releases

Gilead Sciences Invites Investors to Listen to Webcast of Presentation at Goldman Sachs Healthcare Conference; Webcast Available through Gilead Corporate Website

FOSTER CITY, Calif., Jun 9, 2003 (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq:GILD) announced today that its presentation at the Goldman Sachs Twenty Fourth Annual Healthcare Conference will be webcast and may be accessed via the company's corporate website at

John Milligan, Ph.D., Gilead's Senior Vice President and Chief Financial Officer, will provide an overview of the Company and an update on key business milestones on Tuesday, June 10, 2003 at 1:20 p.m. Pacific Time.

To access the live webcast or the seven-day archive via the Internet log on to Please connect to the company's website at least 15 minutes prior to the live presentation to ensure adequate time for any software download that may be needed to view the webcast.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases worldwide. The company has six marketed products and focuses its research and clinical programs on anti-infectives, including antivirals, antifungals and antibacterials. Headquartered in Foster City, Calif., Gilead has operations in the United States, Europe and Australia.

For more information on Gilead Sciences, please visit the company's web site at or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

SOURCE: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Susan Hubbard, 650/522-5715
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.